Literature DB >> 6180852

Characterization of pig lymphocyte receptors for allogeneic and non-allogeneic erythrocytes. I. Apparent common identity of both receptors.

H Salmon.   

Abstract

In the pig thymus, the proportion of allogeneic (or autologous) erythrocyte rosette forming cells (P-RFC) is always lower than that of sheep erythrocyte (non-allogeneic) rosette forming cells (S-RFC) even under saturated RBC/lymphocyte ratios and optimal dextran concentration. This difference accounted for lymphocytes rosetting with sheep erythrocytes and not with pig erythrocytes (P-S+ cells), as opposed to those lymphocytes which are able to bind both types of erythrocytes (P+S+ cells). Since formation of both sheep and pig erythrocyte rosettes is inhibited similarly by anti-T receptor serum, is inhibited reciprocally by sheep and pig erythrocyte membrane fragment and is similarly trypsin sensitive, it was concluded that the same receptor was responsible for both sheep and pig rosette formation. Furthermore it was found that P+S+ cells had a higher avidity for sheep erythrocytes (and lower for pig erythrocytes) than the other subset which did not bind pig erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180852      PMCID: PMC1536598     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Rosette formation with sheep erythrocytes--a possible T-cell marker in the pig.

Authors:  C Escajadillo; R M Binns
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

2.  Inhibitory effect of sheep erythrocyte fragments on rosette formation of human T lymphocytes with sheep red blood cells.

Authors:  N Taniguchi; N Okuda; N Moriya; T Miyawaki; T Nagaoki
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

3.  The significance of varying SRBC/lymphocyte ratio in T cell rosette formation.

Authors:  R L Chisholm; D G Tubergen
Journal:  J Immunol       Date:  1976-05       Impact factor: 5.422

4.  RNA and protein synthesis in spontaneous rosette formation by T lymphocytes.

Authors:  S C Bushkin; V S Pantic; R A Good
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

5.  Studies on the human T-lymphocyte population. II. The use of a T-cell specific antibody in the partial isolation and characterization of the human lymphocyte receptor for sheep red blood cells.

Authors:  F L Owen; M W Fanger
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

6.  Human T lymphocytes form rosettes with autologous and allogeneic human red blood cells.

Authors:  J Kaplan
Journal:  Clin Immunol Immunopathol       Date:  1975-03

7.  Studies of the sheep red blood cell receptor using anti-lymphocyte antibodies.

Authors:  P Small; N Kashiwage; P F Kohler
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

8.  Characterization of autologous erythrocyte rosette-forming cells in Minnesota miniature swine.

Authors:  J W Scheffel; Y B Kim
Journal:  Cell Immunol       Date:  1981-01-01       Impact factor: 4.868

9.  Relationship between E receptors and a T-specific surface antigen on human T cells.

Authors:  C Gattringer; G Wick
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  2 in total

1.  Distribution of T-lymphocyte subsets in porcine lymphoid tissues.

Authors:  N Jonjić; S Jonjić; A Saalmüller; D Rukavina; U H Koszinowski
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

2.  Inhibition of phytohaemagglutinin-induced autorosette formation of human peripheral blood lymphocytes by RNA or protein synthesis inhibitor.

Authors:  S Hyodo; T Kishi; E Kittaka; T Suzawa; A Tanabe; Y Tanaka; T Sakano; T Usui
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.